Rifampin plus pyrazinamide is no longer recommended for latent tuberculosis

September 2003

Rifampin plus pyrazinamide is no longer recommended for latent tuberculosis...due to concerns about hepatotoxicity.

This combo was added to the TB recommendations in 2000.

Its advantage is that it can be given for only 2 to 3 months...compared to 4 to 9 months for the other drug regimens.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Viagra will get competition from Levitra and Cialis
Anticoagulants conventional doses of warfarin to prevent recurrent venous thromboembolism
Anticoagulants Can patients be safely switched from Coumadin to generic warfarin
Infectious Diseases Rifampin plus pyrazinamide is no longer recommended for latent tuberculosis
Infectious Diseases Ciprodex Otic, the newest combo antibiotic/steroid ear drops
Cardiology whether it's okay for heart failure patients to take BOTH aspirin and an ACE inhibitor
Diabetes Can diabetes patients safely use glucosamine for arthritis
Diabetes Precose (acarbose) reduces the risk of heart disease in patients with "pre-diabetes"
Diabetes diabetes type 1.5
Women's Health OTC vaginal antifungal products work as well as Diflucan (fluconazole)
First Aid UrgentQR and NosebleedQR, are now available to stop bleeding from minor cuts or nosebleeds
Uroxatral (uro-ZEH-tral), a new alpha-blocker for benign prostatic hypertrophy
topiramate (Topamax) might be effective for alcohol dependence
Bites & Stings safety of the repellent DEET (Cutter, OFF!, etc) for kids
Obesity & Weight Loss urinary ketone test strips to measure fat burning